Advertisement
Advertisement
XLO
Xilio Therapeutics, Inc. Common Stock
9.04
USDSponsored
+0.02
+0.22%
Sep 22, 15:48 UTC -4
Closed
Pre-Market
9.09
+0.05
+0.50%
Xilio Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 59.78M |
| Beta | -0.14 |
| Earnings Per Share (EPS) | -1.64 |
| Price-to-Book (P/B) Ratio | 0.83 |
| Operating Margin | -48.30% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -71.99% |
| Current Ratio | 4.25% |
| Free Cash Flow | -41.68M |
